1 Gigerenzer G. (2002) Calculated Risks, Simon and Shuster, New York.
2 Pauling L. (1986) How to live longer and feel better, Avon Books, New York.
3 Hoffer A. Vitamin C and Cancer, Quarry Health Books, Quebec, Canada.
4 Cousins N. (1979) Anatomy of an Illness, Bantam Books, New York.
5 Williams R.J. (1998) Biochemical Individuality: The Basis for the Genetotrophic Concept, Keats
Publishing, Connecticut.
6 Huff D. (1954) How to Lie with Statistics, W. W. Norton, New York.
7 Shapiro A.K. (1977) The Powerful Placebo, Johns Hopkins Univ. Press, Baltimore.
8 Rigway P.F. Darzi A.W. (2002) Placebos and standardising new surgical techniques, British
Medical Journal, 325, 560.
9 Fudenburg D. Tirole J. (1991) Game Theory, The M.I.T. Press, Massachusetts.
10 Horrobin D.F. (2003) Are large clinical trials in rapidly lethal diseases usually unethical?
Lancet, 361, 695-697.
11 Pauling L. (1992) My love affair with vitamin C, Linus Pauling Papers, National Library of
Medicine, USA.
12 Barnett A. (2003) Revealed: how drug firms ‘hoodwink’ medical journals, Guardian Online,
Sunday December 7.
13 Newton-Smith W.H. (1981) The Rationality of Science, Routledge and Kegan, London
14 Cathcart R.F. (1985) Vitamin C: The Nontoxic, Nonrate-limited, antioxidant free radical
scavenger, Medical Hypotheses, 18, 61-77
15 T. Kuhn (1962) The Structure of Scientific Revolutions, University of Chicago Press.
16 Moynihan R. (2002) Alosteron: a case study in regulatory capture or a victory for patients
rights? British Medical Journal, 325, 592-595.
17 Lievre M. (2002) Alosteron for irritable bowel syndrome, 325, 555-556.
18 Moynihan R. (2002) FDA advisors warn of more deaths if drug is relaunched, British meical
journal, 325, 561.
19 Keevil J. Lloyd C. Coulter J.L.S. (1957-63) Medicine and the Navy, 1200-1900, Livingstone,
Edinburgh, 4 vols.
20 Harvie D.I. (2002) Limeys, Sutton Publishing, England.
21 Erasmus U. (1993) Fats That Heal, Fats That Kill, Alive Books, Canada.
22 Kunin R.A. (1989) Snake oil, West J Med, 151(2), 208.
23 Smithells R.W. Sheppard S. Schorah C.J. Seller M.J. Nevin N.C. Harris R. Read A.P. Fielding
D.W. (1981) Apparent prevention of neural tube defects by periconceptional vitamin
supplementation, Arch Dis Child, 56(12), 911-918.
24 Smithells R.W. Nevin N.C. Seller M.J. Sheppard S. Harris R. Read A.P. Fielding D.W. Walker
S. Schorah C.J. Wild J. (1983) Further experience of vitamin supplementation for prevention of
neural tube defect recurrences, Lancet, 1(8332), 1027-1031.
25 Mathews T.J. Margaret A. Honein M.A. David Erickson J.D. (2002) Spina Bifida and
Anencephaly Prevalence, United States, 1991-2001, Morbidity and Mortality Weekly Report,
September 13, 51(RR13), 9-11.
26 Michie C.A. (1991) Neural tube defects in 18th century, The Lancet, 337, 504.
27 Hibbard E.D Smithells R.W. (1965) Folic acid metabolism and human embryopathy, The
Lancet, 12 June, 1254.
28 Zempleni J. Mock D.M. (2000) Marginal biotin deficiency is teratogenic, Proc Soc Exp Biol
Med, 223(1), 14-21.
29 Loudon I. (2004) Ignaz Phillip Semmelweis (1818-1865). The James Lind Library
(
Documenting the evolution of fair tests).
30 Bishop W.J. The Early History of Surgery, Oldbourne Science Library, Olbourne Book Co,
London, England.
31 Foreman R. (1981) Medical resistance to innovation, Medical Hypotheses, 7, 8, 1981, 1009-
1017.
32 Popper K.R. (1983) A Pocket Popper, Ed by David Miller, Fontana, Oxford.
33 Popper K.R. (1959) The Logic of Scientific Discovery, Hutchinson, London.
34 Dunbar R. (1995) The Trouble With Science, Faber and Faber, London.
35 Perutz M. (1998) I wish I’d made you angry earlier, Oxford University Press, Oxford, England.
36 Halliwell B. and Gutteridge J.M.C. (1999) Free Radicals in Biology and Medicine, OUP,
Oxford, England.
37 Packer L. Colman C. (1999) The Antioxidant Miracle, Wiley, New York.
38 Buettner G.R. Jurkiewicz B.A. (1993) The ascorbate free radical as a marker of oxidative
stress: An EPR study, Free Radic Biol Med, 14, 49-55.
39 Hossain M.A. Asada K. (1985) Monodehydroascorbate reductase from cucumber is a flavin
adenine dinucleotide enzyme, J Biol Chem, 260, 12920-12926.
40 Buttener G.R. (1993) The pecking order of free radicals and antioxidants: lipid peroxidation,
alpha-tocopherol and ascorbate, Arch Biochem Biophys, 300, 535-543.
41 Buettner G.R. Jurkiewicz B.A. (1996) Catalytic metals, ascorbate, and free radicals:
combinations to avoid, Rad Research, 145, 532-541.
42 Davies I. (1983) Aging, Institute of Biology Series, Arnold, London, England.
43 Turrens J.F. (1997) Superoxide production by the mitochondrial respiratory chain, Biosci Rep,
17, 3.
44 Liu J. Head E. Gharib A.M. Yuan W. Ingersoll R.T. Hagen T.M. Cotman C.W. Ames B.N.
(2002) Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA
oxidation: Partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid, Proc Natl
Acad Sci, USA, 99(4), 2356-2361.
45 Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll RT, Vinarsky V, Bartholomew JC, Ames
BN. (2002) Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic
function while decreasing oxidative stress, Proc Natl Acad Sci, USA, 99(4), 1870-1875.
46 Liu J. Killilea D.W. Ames B.N. (2002) Age-associated mitochondrial oxidative decay:
Improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by
feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid, Proc Natl Acad Sci, USA, 19,
99(4), 1876-1881.
47 Stone I. (1966) On the Genetic Etiology of Scurvy, Acta Geneticae Medicae et Gemellologiae,
15, 345-350.
48 Challem J.J. Taylor E.W. (1998) Retroviruses, ascorbate, and mutations, in the evolution of
Homo sapiens, Free Radic Biol Med, 25(1): 130-132.
49 Bourne G. Allen R. (1935) Vitamin C in lower organisms, Nature, 136, 185-186.
50 Stone I. (1972) The Natural History of Ascorbic Acid in the Evolution of the Mammals and
Primates and Its Significance for Present Day Man, Orthomolecular Psychiatry, 1, 2 & 3, 82-89.
51 Elwood S. McCluskey (1985) Which Vertebrates make vitamin C? Origins, 2(2), 96-100.
52 Salomon L. L. Stubbs D. W. (1961) Some aspects of the metabolism of ascorbic acid in rats,
Ann. N. Y. Acad. Sci., 92, 128-140.
53 Conney A. H. et al. (1961) Metabolic interactions between ascorbic acid and drugs, Ann. N. Y
Acad. Sci., 92, 115-127.
54 Armour J. Tyml K. Lidington D. Wilson J.X. (2001) Ascorbate prevents microvascular
dysfunction in the skeletal muscle of the septic rat, J Appl Physiol, 90(3), 795-803.
55 Conney A. H. Bray C. A. Evans C. Burns J. J. (1961) Metabolic interactions between lascorbic
acid and drugs, Ann N Y Acad. Sc, 92, 115-127.
56 Pauling L. (1970) Evolution and the need for ascorbic acid.. Proc. Nat. Acad. Sc, USA, 67,
1643-1648.
57 Pauling L. (1968) Orthomolecular Psychiatry, Science, 160, 265-271.
58 Cathcart R.F (2003) Personal communication to Dr S. Hickey.
59 Stone I. (1966) Hypoascorbemia, the genetic disease causing the human requirement for
exogenous ascorbic acid, Pers. Biol. Med. 10, 133-134.
60 Stone I. (1967) The Genetic Disease, Hypoascorbemia A Fresh Approach to an Ancient
Disease and Some of its Medical Implications, Acta Geneticae Medicae et Gemellologiae, 16, 1,
52-60.
61 Stone I. (1979) Eight decades of scurvy, the case history of a misleading dietary hypothesis,
Orthomolecular Psychiatry, 8, 2, 58-62.
62 Expert Group on Vitamins and Minerals (1999), UK government update paper EVM/99/21/P.
63 Levine M. Conry-Cantilena C. Wang Y. Welch R. W. Phillip W. Washko P.W. Dhariwal K.R.
Park J.B. Lazarrev A. Graumlich J.F. King J. Cantilena L.R. (1996) Vitamin C pharmacokinetics
in healthy volunteers: Evidence for a recommended dietary allowance, Proc. Natl. Acad. Sci.
USA, 93, 3704–3709.
64Standing Committee on Dietary reference Intakes (2000), Dietary Reference Intakes for
Vitamin C, Vitamin E, Selenium, and Carotenoids: A Report of the Panel on Dietary Antioxidants
and Related Compounds, Institute of Medicine, National Acadamy Press, USA.
65 Levine M. Wang Y. Padayatty S.J. Morrow J. (2001) A new recommended dietary allowance
of vitamin C for healthy young women Proc. Natl. Acad. Sci. USA, 14, 98 (17), 9842-9846.
66 Kallner A. Hartmann I. Hornig D. (1979) Steady-state turnover and body pool of ascorbic acid
in man. American Journal of Clinical Nutrition, 32, 530-539.
67 Baker E.M. Hodges R.E. Hood J. Sauberlich H.E. March S.C. (1969) Metabolism of ascorbic-
1-14C acid in experimental human scurvy. American Journal of Clinical Nutrition, 22, No. 5, 549-
558.
68 Kallner A. Hartmann I. Hornig D. (1977) On the absorption of ascorbic acid in man.
International Journal of Vitamin and Nutrition Research, 47, 383-388.
69 Hornig, D.H. and Moser, U. (1981) The safety of high vitamin C intakes in man. In: Vitamin C
(ascorbic acid). Eds. Counsell, J.N. and Hornig, D.H., Applied Science Publishers, New Jersey,
225-248.
70 Kallner, A. Hartmann I. Hornig D. (1981) On the requirements of ascorbic acid in man:
steady-state turnover and body pool in smokers. American Journal of Clinical Nutrition, 34,
1347-1355.
71 Young V.R. (1996) Evidence for a recommended dietary allowance for vitamin C from
pharmacokinetics: A comment and analysis, Proc. Natl. Acad. Sci, USA, 93, 14344–14348.
72 Ginter E. (2002) Current views of the optimum dose of vitamin C, Slovakofarma Revue XII, 1,
4-8.
73 Padayatty S.J. Sun H. Wang Y. Riordan H.D. Hewitt S.M. Katz A. Wesley R.A. Levine M.
(2004) Vitamin C pharmacokinetics: implications for oral and intravenous use, Ann Intern Med,
140(7), 533-537.
74 Benke K.K. (1999) Modelling Ascorbic Acid Level in Plasma and Its Dependence on
Absorbed Dose, Journal of the Australasian College of Nutritional & Environmental Medicine,
18(1), 11-12.
75 Hornig D. (1975) Distribution of ascorbic acid, metabolites and analogues in man and
animals, Ann NY Acad Sci, 258, 103-118.
76 Moser U. (1987) The uptake of ascorbic acid by leukocytes, Ann NY Acad Sci, 198, 200-215.
77 Watson R.W.G (2002) Forum Review, Redox Regulation of Neutrophil Apoptosis,
Antioxidants and redox signaling, 4, 1, 97-104.
78 Kinnula V.L. Soini Y. Kvist-Makela K. Savolainen E. Koisinen P. (2002) Antioxidant Defense
Mechanisms in Human Neutrophils, Antioxidants and redox signaling, 4, 1, 27-34.
79 Daruwala R. Song J. Koh W.S. Rumsey S.C. Levine M. (1999) Cloning and functional
characterization of the human sodium-dependent vitamin C transporters hSVCT1 and hSVCT2,
FEBS Lett, 5, 460(3), 480-484.
80 Tsukaguchi H. Tokui T. Mackenzie B. Berger U.V. Chen X.Z. Wang Y. Brubaker R.F. Hediger
M.A. (1999) A family of mammalian Na+-dependent L-ascorbic acid transporters, Nature, 399,
70-75.
81 Omaye S.T. Schous E.E. Kutnink M.A. Hawkes W.C. (1987) Measurement of vitamin C in
blood components by high performance liquid chromatography, implications in assessing vitamin
C status, Ann NY Acad Sci, 498, 389-401.
82 Perret J.L. Lagauche D. Favier J.C. Rey P. Bigois L. Adam F. (2004) Scurvy in intensive care
despite vitamin supplementation, Presse Med, 33(3), 170-171.
83 Ruiz E. Siow R.C.M. Bartlett S.R. Jenner A.M. Sato H. Bannai S. Mann G.E. (2003) Vitamin C
inhibits diethylmaleate-induced L-cystine transport in human vascular smooth muscle cells, Free
Radical Biology and Medicine, 34 (1) 103-110.
84 Fletcher AE, Breeze E, Shetty P.S. (2003) Antioxidant vitamins and mortality in older persons:
findings from the nutrition add-on study to the Medical Research Council Trial of Assessment
and Management of Older People in the Community, Am J Clin Nutr, 78(5), 999-1010.
85 Halliwell B. Zhao K. Whiteman M. (2001) The Gastrointestinal Tract: A Major Site of
Antioxidant Action? Free Radic Res, 33(6), 819-830.
86 Ekstrom A.M. Serafini M. Nyren O. Hansson L.E. Ye W. Wolk A. (2000) Dietary antioxidant
intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a
population-based case-control study in Sweden, Int J Cancer, 87(1), 133-140.
87 Martin M. Ferrier B. Roch-Ramel F. (1983) Renal excretion of ascorbic acid in the rat: a
micropuncture study, Am J Physiol. 1983 Mar; 244(3),335-341.
88 Karlinsky N. (2002) Good Morning America, Sept 18.
89 Baranowitz SA, Maderson PF (1995) Acetaminophen toxicity is substantially reduced by betacarotene
in mice, Int J Vitam Nutr Res, 65(3), 175-180.
90 Hong R.W. Rounds J.D. Helton W.S. Robinson M.K. Wilmore D.W. (1992) Glutamine
preserves liver glutathione after lethal hepatic injury, Ann Surg, 215(2), 114-119.
91 Schnell R.C. Park K.S. Davies M.H. Merrick B.A. Weir S.W.(1988) Protective effects of
selenium on acetaminophen-induced hepatotoxicity in the rat, Toxicol Appl Pharmacol, 95(1), 1-
11.
92 Ostapowicz G. Fontana R.J. Schiødt F.V. Larson A. Davern T.J. Han S.H.B. McCashland
T.M. Shakil A.O. Hay J.E. Hynan L. Crippin J.S. Blei A.T. Samuel G. Reisch J. Lee W.M. (2002)
Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United
States, Annals of Internal Medicine, 137, 947-954.
93 Gurkirpal S. (1998) Recent Considerations in Nonsteroidal Anti-Inflammatory Drug
Gastropathy, The American Journal of Medicine, July 27, 31S.
94 Wolfe M. Lichtenstein D. Gurkirpal S. (1999) Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory
Drugs, N Engl J Med, 340(24) 1888-1889.
95 Kohn L. Corrigan J. Donaldson M. (1999) To Err Is Human: Building a Safer Health System.
Washington, DC: National Academy Press.
96 Leape L.L.(1992) Unnecessary surgery, Annu Rev Public Health, 13, 363-383.